Global Erythromycin Thiocyanate API 麻豆原创 Growth 2024-2030

Publication ID:

LPI10249626

Publication Date:

October 14, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Manufacturing (Chemicals) [2]

Chemicals [3]

Description:

Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
The global Erythromycin Thiocyanate API market size is projected to grow from US$ 1613 million in 2024 to US$ 2251 million in 2030; it is expected to grow at a CAGR of 5.7% from 2024 to 2030.
The 鈥淓rythromycin Thiocyanate API Industry Forecast鈥� looks at past sales and reviews total world Erythromycin Thiocyanate API sales in 2023, providing a comprehensive analysis by region and market sector of projected Erythromycin Thiocyanate API sales for 2024 through 2030. With Erythromycin Thiocyanate API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Erythromycin Thiocyanate API industry.
This Insight Report provides a comprehensive analysis of the global Erythromycin Thiocyanate API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Erythromycin Thiocyanate API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Erythromycin Thiocyanate API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Erythromycin Thiocyanate API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Erythromycin Thiocyanate API.
United States market for Erythromycin Thiocyanate API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Erythromycin Thiocyanate API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Erythromycin Thiocyanate API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Erythromycin Thiocyanate API players cover Yili Chuannig Biotechnology, Yichang East Sunshine, Alebi Pharma, META Pharmaceuticals, Anuh Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Erythromycin Thiocyanate API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Industrial Grade
Feed Grade
Pharmaceutical Grade
Segmentation by Application:
Erythromycin Synthesis
Feed Additive
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Yili Chuannig Biotechnology
Yichang East Sunshine
Alebi Pharma
META Pharmaceuticals
Anuh Pharma
HEC Group
AbbVie
Key Questions Addressed in this Report
What is the 10-year outlook for the global Erythromycin Thiocyanate API market?
What factors are driving Erythromycin Thiocyanate API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Erythromycin Thiocyanate API market opportunities vary by end market size?
How does Erythromycin Thiocyanate API break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Erythromycin Thiocyanate API Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Erythromycin Thiocyanate API by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Erythromycin Thiocyanate API by Country/Region, 2019, 2023 & 2030
2.2 Erythromycin Thiocyanate API Segment by Type
2.2.1 Industrial Grade
2.2.2 Feed Grade
2.2.3 Pharmaceutical Grade
2.3 Erythromycin Thiocyanate API Sales by Type
2.3.1 Global Erythromycin Thiocyanate API Sales 麻豆原创 Share by Type (2019-2024)
2.3.2 Global Erythromycin Thiocyanate API Revenue and 麻豆原创 Share by Type (2019-2024)
2.3.3 Global Erythromycin Thiocyanate API Sale Price by Type (2019-2024)
2.4 Erythromycin Thiocyanate API Segment by Application
2.4.1 Erythromycin Synthesis
2.4.2 Feed Additive
2.5 Erythromycin Thiocyanate API Sales by Application
2.5.1 Global Erythromycin Thiocyanate API Sale 麻豆原创 Share by Application (2019-2024)
2.5.2 Global Erythromycin Thiocyanate API Revenue and 麻豆原创 Share by Application (2019-2024)
2.5.3 Global Erythromycin Thiocyanate API Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Erythromycin Thiocyanate API Breakdown Data by Company
3.1.1 Global Erythromycin Thiocyanate API Annual Sales by Company (2019-2024)
3.1.2 Global Erythromycin Thiocyanate API Sales 麻豆原创 Share by Company (2019-2024)
3.2 Global Erythromycin Thiocyanate API Annual Revenue by Company (2019-2024)
3.2.1 Global Erythromycin Thiocyanate API Revenue by Company (2019-2024)
3.2.2 Global Erythromycin Thiocyanate API Revenue 麻豆原创 Share by Company (2019-2024)
3.3 Global Erythromycin Thiocyanate API Sale Price by Company
3.4 Key Manufacturers Erythromycin Thiocyanate API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Erythromycin Thiocyanate API Product Location Distribution
3.4.2 Players Erythromycin Thiocyanate API Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Erythromycin Thiocyanate API by Geographic Region
4.1 World Historic Erythromycin Thiocyanate API 麻豆原创 Size by Geographic Region (2019-2024)
4.1.1 Global Erythromycin Thiocyanate API Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Erythromycin Thiocyanate API Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Erythromycin Thiocyanate API 麻豆原创 Size by Country/Region (2019-2024)
4.2.1 Global Erythromycin Thiocyanate API Annual Sales by Country/Region (2019-2024)
4.2.2 Global Erythromycin Thiocyanate API Annual Revenue by Country/Region (2019-2024)
4.3 Americas Erythromycin Thiocyanate API Sales Growth
4.4 APAC Erythromycin Thiocyanate API Sales Growth
4.5 Europe Erythromycin Thiocyanate API Sales Growth
4.6 Middle East & Africa Erythromycin Thiocyanate API Sales Growth
5 Americas
5.1 Americas Erythromycin Thiocyanate API Sales by Country
5.1.1 Americas Erythromycin Thiocyanate API Sales by Country (2019-2024)
5.1.2 Americas Erythromycin Thiocyanate API Revenue by Country (2019-2024)
5.2 Americas Erythromycin Thiocyanate API Sales by Type (2019-2024)
5.3 Americas Erythromycin Thiocyanate API Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Erythromycin Thiocyanate API Sales by Region
6.1.1 APAC Erythromycin Thiocyanate API Sales by Region (2019-2024)
6.1.2 APAC Erythromycin Thiocyanate API Revenue by Region (2019-2024)
6.2 APAC Erythromycin Thiocyanate API Sales by Type (2019-2024)
6.3 APAC Erythromycin Thiocyanate API Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Erythromycin Thiocyanate API by Country
7.1.1 Europe Erythromycin Thiocyanate API Sales by Country (2019-2024)
7.1.2 Europe Erythromycin Thiocyanate API Revenue by Country (2019-2024)
7.2 Europe Erythromycin Thiocyanate API Sales by Type (2019-2024)
7.3 Europe Erythromycin Thiocyanate API Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Erythromycin Thiocyanate API by Country
8.1.1 Middle East & Africa Erythromycin Thiocyanate API Sales by Country (2019-2024)
8.1.2 Middle East & Africa Erythromycin Thiocyanate API Revenue by Country (2019-2024)
8.2 Middle East & Africa Erythromycin Thiocyanate API Sales by Type (2019-2024)
8.3 Middle East & Africa Erythromycin Thiocyanate API Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Erythromycin Thiocyanate API
10.3 Manufacturing Process Analysis of Erythromycin Thiocyanate API
10.4 Industry Chain Structure of Erythromycin Thiocyanate API
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Erythromycin Thiocyanate API Distributors
11.3 Erythromycin Thiocyanate API Customer
12 World Forecast Review for Erythromycin Thiocyanate API by Geographic Region
12.1 Global Erythromycin Thiocyanate API 麻豆原创 Size Forecast by Region
12.1.1 Global Erythromycin Thiocyanate API Forecast by Region (2025-2030)
12.1.2 Global Erythromycin Thiocyanate API Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Erythromycin Thiocyanate API Forecast by Type (2025-2030)
12.7 Global Erythromycin Thiocyanate API Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Yili Chuannig Biotechnology
13.1.1 Yili Chuannig Biotechnology Company Information
13.1.2 Yili Chuannig Biotechnology Erythromycin Thiocyanate API Product Portfolios and Specifications
13.1.3 Yili Chuannig Biotechnology Erythromycin Thiocyanate API Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Yili Chuannig Biotechnology Main Business Overview
13.1.5 Yili Chuannig Biotechnology Latest Developments
13.2 Yichang East Sunshine
13.2.1 Yichang East Sunshine Company Information
13.2.2 Yichang East Sunshine Erythromycin Thiocyanate API Product Portfolios and Specifications
13.2.3 Yichang East Sunshine Erythromycin Thiocyanate API Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Yichang East Sunshine Main Business Overview
13.2.5 Yichang East Sunshine Latest Developments
13.3 Alebi Pharma
13.3.1 Alebi Pharma Company Information
13.3.2 Alebi Pharma Erythromycin Thiocyanate API Product Portfolios and Specifications
13.3.3 Alebi Pharma Erythromycin Thiocyanate API Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Alebi Pharma Main Business Overview
13.3.5 Alebi Pharma Latest Developments
13.4 META Pharmaceuticals
13.4.1 META Pharmaceuticals Company Information
13.4.2 META Pharmaceuticals Erythromycin Thiocyanate API Product Portfolios and Specifications
13.4.3 META Pharmaceuticals Erythromycin Thiocyanate API Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 META Pharmaceuticals Main Business Overview
13.4.5 META Pharmaceuticals Latest Developments
13.5 Anuh Pharma
13.5.1 Anuh Pharma Company Information
13.5.2 Anuh Pharma Erythromycin Thiocyanate API Product Portfolios and Specifications
13.5.3 Anuh Pharma Erythromycin Thiocyanate API Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Anuh Pharma Main Business Overview
13.5.5 Anuh Pharma Latest Developments
13.6 HEC Group
13.6.1 HEC Group Company Information
13.6.2 HEC Group Erythromycin Thiocyanate API Product Portfolios and Specifications
13.6.3 HEC Group Erythromycin Thiocyanate API Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 HEC Group Main Business Overview
13.6.5 HEC Group Latest Developments
13.7 AbbVie
13.7.1 AbbVie Company Information
13.7.2 AbbVie Erythromycin Thiocyanate API Product Portfolios and Specifications
13.7.3 AbbVie Erythromycin Thiocyanate API Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 AbbVie Main Business Overview
13.7.5 AbbVie Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.